총 게시물 360건
Harnessing nature’s secret: How synthetic biology could save the planet
The impacts of humanity on the Earth are massive. Arable land is transformed for agriculture; plastics litter the planet; the very atmosphere is warming with carbon emissions and greenhouse gases, hotboxing us. What if solutions to these complex problems could be found in the very building blocks of life itself?
Turning up heat to unlock Cas13’s potential
A protein from a heat-loving bacterium allows specific detection of SARS-CoV-2 and other viruses in a one-pot assay based on RT-LAMP technology. Such a test could simplify point-of-care diagnoses of COVID-19 and other infections.RT-LAMP tests are similar to PCR tests: they detect tiny amounts of viral genetic material in a sample by amplifying it to detectable amounts.
DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound
DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health, announced today a new research collaboration with Kelai Pharmaceuticals (“Kelai”) to explore the potential of biosynthetic kavalactone therapeutics. Kelai will include one of Double Rainbow’s molecules in their ongoing cell transcriptome study. Additionally, the two organizations will pair Kelai’s patented advanced drug delivery systems with the leading plant natural product biosynthesis capabilities of Double Rainbow to explore new opportunities for sustainable therapeutics.
Viewpoint: New European Innovation Agenda to speed development and scale-up of innovation across Europe
Innovation is critical to navigate the twin green and digital transitions and to secure the EU’s strategic autonomy. The New European Innovation Agenda, adopted by the Commission in July, aims to unlock Europe’s innovation potential, and ensure its leading role on the global innovation scene, so that it becomes a place where deep tech innovation creates cutting-edge solutions across the continent.
Constructive Bio launched to build on synthetic biology breakthroughs.
Based in Cambridge, UK, Constructive Bio, the latest LMB spinout, aims to re-engineer biology, creating new classes of enzymes, drugs and biomaterials, building upon research and technologies developed by Jason Chin’s group in the LMB’s PNAC Division.
Scientists plan multi-million dollar resurrection of Tasmanian Tiger, last seen in 1936
Scientists are embarking on a multi-million dollar project to bring back to life an Australian wolf-like, striped marsupial that went extinct nearly 100 years ago. Texas-based company Colossal Biosciences and Harvard Medical School geneticist George Church aim to resurrect the thylacine, or the Tasmanian tiger, that was last seen in 1936.
Ginkgo Bioworks Announces Strategic Purchase of Epidemiological Data Infrastructure Assets.
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the purchase of certain epidemiological data infrastructure assets from Baktus, Inc., a Delaware-based public benefit corporation. Under the terms of the deal, Ginkgo will assume ownership of proprietary datasets, modeling and analytic tools, and a software platform with the capabilities to track, model, and forecast epidemics and associated risks and impacts. Ginkgo also expects to integrate several ongoing epidemiological analysis projects and a team of epidemiological data experts into its biosecurity and public health initiative, Concentric by Ginkgo.
A STEP TOWARD THE CREATION OF MATERIALS CONTROLLED BY ARTIFICIAL GENES.
Our bodies' genes work together to regulate how our cells behave. For example, if you skin your knee, your genes use a chemical messaging system to direct an army of cells to heal the abrasion. If scientists could create artificial genes that could carry out the same functions but operate inside materials rather than organisms, a wide variety of new diagnostic, self-healing materials would be possible.
Could Carbon-Negative Cellulosic Textiles be the Answer?
Turning carbon emissions into carbon-negative textiles with synthetic biology, they are on a mission to build the world’s most sustainable supply chains for people and planet. The good news is that Rubi technology has the potential to be the turn-key solution that could revolutionise the supply chain to remove CO2 from the atmosphere with every garment created.
Ramping Up the World of Bio-fabrication
Bioprinting has been defined as the deposition of biological materials together with living cells layer-by-layer using computer-aided transfer processes. It is an additive manufacturing technology. The building of heterogeneous compositions and complex architectures has been enabled by 3D bioprinting using various techniques, including Inkjet, Extrusion, and Laser.